Brian Wilhelm awarded with major funding through the new Genomics Integration Program – Human Health initiated by Génome Québec
Published on June 21, 2021
Brian Wilhelm, Principal Investigator at IRIC and Associate Professor in the Department of Medicine at the Faculty of Medicine of the Université de Montréal, is the recipient of major funding through the new Genomics Integration Program – Human Health, initiated by Génome Québec in collaboration with the Oncopole. He has been awarded $150,000 by Génome Québec and $50,000 by Oncopole for a total of $200,000 by July 1st, 2021, for his project on the Use of chemogenomic data to improve drug prediction based on machine learning.
Génome Québec awarded 12 research teams from four Quebec universities with major funding in genomics.
This program is part of the desire to build new bridges between the private sector and researchers working on genomics health solutions. The program offers co-funding ranging from $50,000 to $200,000, with equal or greater participation from partners. This first round focuses on partnerships between academic researchers and users capable of implementing or commercializing research results in order to bring technology to maturity.
In 2010, Brian Wilhelm launched his laboratory, IRIC’s High-Throughput Genomics Research Unit, and started as a professor in the Department of Medicine at the University of Montreal. The goal of his research is to elucidate the molecular biology of pediatric leukemia and to use this knowledge to develop more effective and targeted treatments.